Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New diabetes program for Filipino-Americans shows promise

NCT ID NCT05378620

Disease control Sponsor: Scripps Whittier Diabetes Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a culturally adapted diabetes self-management program for Filipino-Americans with type 2 diabetes. The program combined group classes taught in Tagalog with text message support. Researchers measured changes in diabetes knowledge, self-confidence, and blood sugar control over 6 months in 29 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Project Dulce (group diabetes self-management education) plus Dulce Digital (text messaging support)
What this could lead to
If successful, this program could help Filipino-Americans better manage their diabetes, leading to improved blood sugar control and fewer complications.
What could go wrong
This is a small, completed study with only 29 participants, so results may not apply to everyone. The program relies on participants' willingness to engage and may not work for those with severe illness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

29 people

The number who actually took part.

Started

Oct 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identified Filipino * Diagnosed with T2DM * Registered at Scripps Health or San Ysidro Health (or willing to register) * HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days * Able to speak, read, write, and comprehend in English and Tagalog * Have access to a cell phone that can receive/send text messages throughout the study Exclusion Criteria: * Severe illness precluding frequent visits to clinic * Liver function tests (ALT and AST) \> 3 times the upper limit of normal * Body mass index ≤ 23 kg/cm * History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma * Creatinine \>3.5 * History of drug or alcohol abuse within 12 months prior to enrollment * Not a permanent resident in the area * Current enrollee in Project Dulce * Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening * Anemia * Type 1 or gestational diabetes * Pregnant * Are currently participating in another diabetes-related study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes type 2

Contacts and locations

Locations

  • San Ysidro Health

    National City, California, 91950, United States

  • Scripps Whittier Diabetes Institute

    San Diego, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.